Bicyclic 1,4-Dioxepanes for Drug Discovery: Multigram Synthesis, Physicochemical, and Structural Characterization.
Andrii V Bondarenko1,2, Yevhenii Kozyriev1,3, Illia O Doroshenko2,4
1Enamine Ltd., Kyїv, Ukraine.
Chemistry (Weinheim an Der Bergstrasse, Germany)
|December 29, 2025
Summary
Novel fused and spirocyclic 1,4-dioxepanes with heterocyclic amine rings show promise for drug discovery. Efficient synthesis and functionalization create versatile building blocks for further research.
Area of Science:
- Medicinal Chemistry
- Organic Synthesis
- Drug Discovery
Background:
- Fused and spirocyclic 1,4-dioxepanes are underexplored scaffolds in medicinal chemistry.
- Incorporating saturated heterocyclic amine rings offers unique structural and physicochemical properties.
Purpose of the Study:
- To develop efficient synthetic routes to novel fused and spirocyclic 1,4-dioxepanes.
- To explore the potential of these compounds as building blocks for early drug discovery.
- To evaluate their suitability for isosteric replacement strategies.
Main Methods:
- Double alkylation of N-heterocyclic 1,2-diols with α,α'-dichloroisobutylene.
- Chemical modification of exocyclic double bonds in bicyclic intermediates.
- Physicochemical profiling (pKa, LogP) and conformational analysis (X-ray diffraction, virtual libraries).
Main Results:
- High-efficiency, multigram-scale synthesis of target dioxepanes achieved.
- Versatile building blocks with common functional groups were generated.
- Physicochemical and conformational data support their potential for isosteric replacement.
Conclusions:
- The developed synthetic protocols are efficient and scalable.
- The synthesized dioxepanes represent valuable scaffolds for drug discovery programs.
- These compounds offer promising opportunities for isosteric modifications in lead optimization.
Related Concept Videos
Drug Discovery: Overview
10.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.9K
Cycloaddition Reactions: Overview
3.3K
Cycloadditions are one of the most valuable and effective synthesis routes to form cyclic compounds. These are concerted pericyclic reactions between two unsaturated compounds resulting in a cyclic product with two new σ bonds formed at the expense of π bonds. The [4 + 2] cycloaddition, known as the Diels–Alder reaction, is the most common. The other example is a [2 + 2] cycloaddition.
3.3K
Diels–Alder Reaction Forming Bridged Bicyclic Products: Stereochemistry
5.3K
Diels–Alder reactions between cyclic dienes locked in an s-cis configuration and dienophiles yield bridged bicyclic products.
5.3K
[4+2] Cycloaddition of Conjugated Dienes: Diels–Alder Reaction
12.1K
The Diels–Alder reaction is an example of a thermal pericyclic reaction between a conjugated diene and an alkene or alkyne, commonly referred to as a dienophile. The reaction involves a concerted movement of six π electrons, four from the diene and two from the dienophile, forming an unsaturated six-membered ring. As a result, these reactions are classified as [4+2] cycloadditions.
12.1K
Diels–Alder Reaction Forming Cyclic Products: Stereochemistry
4.6K
The Diels–Alder reaction is one of the robust methods for synthesizing unsaturated six-membered rings. The reaction involves a concerted cyclic movement of six π electrons: four π electrons from the diene and two π electrons from the dienophile.
4.6K
Structure-Activity Relationships and Drug Design
1.6K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.6K

![Solid-phase Synthesis of [4.4] Spirocyclic Oximes](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F58508.jpg&w=3840&q=50)
